Middle East Healthcare Company
Middle East Healthcare Company (4009.SR) Revenue
Annual & quarterly revenue history · segment & region breakdown
4009.SR · revenue · updated Jun 15, 2026
Core revenue metrics
Trailing 12 monthsMiddle East Healthcare Company trailing twelve-month (TTM) revenue is $3.13B, an increase of 7.62% year-over-year from $3.10B in FY2025.
Revenue trend
2025 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $3.10B | +$0.22B | +7.62% |
| 2024-12-31 | $2.88B | +$0.23B | +8.66% |
| 2023-12-31 | $2.65B | +$0.50B | +23.30% |
| 2022-12-31 | $2.15B | +$0.28B | +14.91% |
| 2021-12-31 | $1.87B | +$0.10B | +5.67% |
| 2020-12-31 | $1.77B | +$0.28B | +18.41% |
| 2019-12-31 | $1.50B | +$0.11B | +7.62% |
| 2018-12-31 | $1.39B | -$0.24B | -14.65% |
| 2017-12-31 | $1.63B | +$0.01B | +0.85% |
| 2016-12-31 | $1.62B | +$0.08B | +5.29% |
Compare revenue vs peers
Medical - Care FacilitiesCompare 4009.SR revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Middle East Healthcare Company receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Middle East Healthcare Company reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in SAR.
Data sourced from Middle East Healthcare Company's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
4009.SR revenue · 4 questions4009.SR's trailing twelve-month (TTM) revenue is $3.13B. That is an increase of 7.62% year-over-year from $3.10B in FY2025.
▸ Source: FMP · Middle East Healthcare Company SEC filings · GAAP · Middle East Healthcare Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 15, 2026